{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:49:12Z","timestamp":1787028552520,"version":"build-2736575974"},"reference-count":88,"publisher":"MDPI AG","issue":"24","license":[{"start":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T00:00:00Z","timestamp":1734048000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["\u2116 20-14-00074-P"],"award-info":[{"award-number":["\u2116 20-14-00074-P"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Multiple myeloma (MM) is characterized by the uncontrolled proliferation of monoclonal plasma cells and accounts for approximately 10% of all hematologic malignancies. The clinical outcomes of MM can exhibit considerable variability. Variability in both the genetic and epigenetic characteristics of MM undeniably contributes to tumor dynamics. The aim of the present study was to identify biomarkers with the potential to improve the accuracy of prognosis assessment in MM. Initially, miRNA sequencing was conducted on bone marrow (BM) samples from patients with MM. Subsequently, the expression levels of 27 microRNAs (miRNA) and the gene expression levels of ASF1B, CD82B, CRISP3, FN1, MEF2B, PD-L1, PPAR\u03b3, TERT, TIMP1, TOP2A, and TP53 were evaluated via real-time reverse transcription polymerase chain reaction in BM samples from patients with MM exhibiting favorable and unfavorable prognoses. Additionally, the analysis involved the bone marrow samples from patients undergoing examinations for non-cancerous blood diseases (NCBD). The findings indicate a statistically significant increase in the expression levels of miRNA-124, -138, -10a, -126, -143, -146b, -20a, -21, -29b, and let-7a and a decrease in the expression level of miRNA-96 in the MM group compared with NCBD (p &lt; 0.05). No statistically significant differences were detected in the expression levels of the selected miRNAs between the unfavorable and favorable prognoses in MM groups. The expression levels of ASF1B, CD82B, and CRISP3 were significantly decreased, while those of FN1, MEF2B, PDL1, PPAR\u03b3, and TERT were significantly increased in the MM group compared to the NCBD group (p &lt; 0.05). The MM group with a favorable prognosis demonstrated a statistically significant decline in TIMP1 expression and a significant increase in CD82B and CRISP3 expression compared to the MM group with an unfavorable prognosis (p &lt; 0.05). From an empirical point of view, we have established that the complex biomarker encompassing the CRISP3\/TIMP1 expression ratio holds promise as a prognostic marker in MM. From a fundamental point of view, we have demonstrated that the development of MM is rooted in a cascade of complex molecular pathways, demonstrating the interplay of genetic and epigenetic factors.<\/jats:p>","DOI":"10.3390\/ijms252413404","type":"journal-article","created":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T04:14:52Z","timestamp":1734322492000},"page":"13404","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Multiple Myeloma: Genetic and Epigenetic Biomarkers with Clinical Potential"],"prefix":"10.3390","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3799-9407","authenticated-orcid":false,"given":"Yuliya A.","family":"Veryaskina","sequence":"first","affiliation":[{"name":"Laboratory of Molecular Genetics, Department of the Structure and Function of Chromosomes, Institute of Molecular and Cellular Biology, Siberian Branch of the Russian Academy of Sciences, Novosibirsk 630090, Russia"},{"name":"Laboratory of Gene Engineering, Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of Sciences, Novosibirsk 630090, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9401-5737","authenticated-orcid":false,"given":"Sergei E.","family":"Titov","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Genetics, Department of the Structure and Function of Chromosomes, Institute of Molecular and Cellular Biology, Siberian Branch of the Russian Academy of Sciences, Novosibirsk 630090, Russia"},{"name":"AO Vector-Best, Novosibirsk 630117, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6938-3802","authenticated-orcid":false,"given":"Natalia V.","family":"Skvortsova","sequence":"additional","affiliation":[{"name":"Department of Therapy, Hematology and Transfusiology, Novosibirsk State Medical University, Novosibirsk 630091, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor B.","family":"Kovynev","sequence":"additional","affiliation":[{"name":"Department of Therapy, Hematology and Transfusiology, Novosibirsk State Medical University, Novosibirsk 630091, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oksana V.","family":"Antonenko","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Genetics, Department of the Structure and Function of Chromosomes, Institute of Molecular and Cellular Biology, Siberian Branch of the Russian Academy of Sciences, Novosibirsk 630090, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergei A.","family":"Demakov","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Genetics, Department of the Structure and Function of Chromosomes, Institute of Molecular and Cellular Biology, Siberian Branch of the Russian Academy of Sciences, Novosibirsk 630090, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9433-8341","authenticated-orcid":false,"given":"Pavel S.","family":"Demenkov","sequence":"additional","affiliation":[{"name":"Laboratory of Computer Proteomics, Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of Sciences, Novosibirsk 630090, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana I.","family":"Pospelova","sequence":"additional","affiliation":[{"name":"Department of Therapy, Hematology and Transfusiology, Novosibirsk State Medical University, Novosibirsk 630091, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7503-2435","authenticated-orcid":false,"given":"Mikhail K.","family":"Ivanov","sequence":"additional","affiliation":[{"name":"AO Vector-Best, Novosibirsk 630117, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor F.","family":"Zhimulev","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Genetics, Department of the Structure and Function of Chromosomes, Institute of Molecular and Cellular Biology, Siberian Branch of the Russian Academy of Sciences, Novosibirsk 630090, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,12,13]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Utley, A., Lipchick, B., Lee, K.P., and Nikiforov, M.A. (2020). Targeting Multiple Myeloma through the Biology of Long-Lived Plasma Cells. Cancers, 12.","DOI":"10.3390\/cancers12082117"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1178224219868235","DOI":"10.1177\/1178224219868235","article-title":"Multiple myeloma: An overview of management","volume":"13","author":"Bird","year":"2019","journal-title":"Palliat. Care Soc. Pract."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Wiedmeier-Nutor, J.E., and Bergsagel, P.L. (2022). Review of Multiple Myeloma Genetics including Effects on Prognosis, Response to Treatment, and Diagnostic Workup. Life, 12.","DOI":"10.3390\/life12060812"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Cardona-Benavides, I.J., de Ram\u00f3n, C., and Guti\u00e9rrez, N.C. (2021). Genetic Abnormalities in Multiple Myeloma: Prognostic and Therapeutic Implications. Cells, 10.","DOI":"10.3390\/cells10020336"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/s41571-018-0018-y","article-title":"The multiple myelomas\u2014Current concepts in cytogenetic classification and therapy","volume":"15","author":"Kumar","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1182\/blood-2010-04-279596","article-title":"A compendium of myeloma-associated chromosomal copy number abnormalities and their prognostic value","volume":"116","author":"Walker","year":"2010","journal-title":"Blood"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Wang, W., Xu, S.W., Zhu, X.Y., Guo, Q.Y., Zhu, M., Mao, X.L., Chen, Y.H., Li, S.W., and Luo, W.D. (2021). Identification and Validation of a Novel RNA-Binding Protein-Related Gene-Based Prognostic Model for Multiple Myeloma. Front. Genet., 12.","DOI":"10.3389\/fgene.2021.665173"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Soliman, A.M., Lin, T.S., Mahakkanukrauh, P., and Das, S. (2020). Role of microRNAs in Diagnosis, Prognosis and Management of Multiple Myeloma. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21207539"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1177\/1947601910396213","article-title":"MicroRNA in Cancer: The Involvement of Aberrant MicroRNA Biogenesis Regulatory Pathways","volume":"1","author":"Hata","year":"2010","journal-title":"Genes Cancer"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e16711","DOI":"10.1097\/MD.0000000000016711","article-title":"MiRNAs with prognostic significance in multiple myeloma: A systemic review and meta-analysis","volume":"98","author":"Xu","year":"2019","journal-title":"Medicine"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Pu\u0142a, A., Robak, P., Jarych, D., Mikulski, D., Misiewicz, M., Drozdz, I., Fendler, W., Szemraj, J., and Robak, T. (2023). The Relationship between Serum miRNAs and Early Mortality in Multiple Myeloma Patients Treated with Bortezomib-Based Regimens. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24032938"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Che, F., Wan, C., Dai, J., and Chen, J. (2019). Increased expression of miR-27 predicts poor prognosis and promotes tumorigenesis in human multiple myeloma. Biosci. Rep., 39.","DOI":"10.1042\/BSR20182502"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/j.leukres.2012.08.021","article-title":"MiR-15a, miR-16-1 and miR-17-92 cluster expression are linked to poor prognosis in multiple myeloma","volume":"36","author":"Gao","year":"2012","journal-title":"Leuk. Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1182\/blood.2019004309","article-title":"Risk factors in multiple myeloma: Is it time to reconsider?","volume":"137","author":"Corre","year":"2021","journal-title":"Blood"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"B\u0119bnowska, D., Hrynkiewicz, R., Grywalska, E., Pasiarski, M., Sosnowska-Pasiarska, B., Smarz-Widelska, I., G\u00f3\u017ad\u017a, S., Roli\u0144ski, J., and Nied\u017awiedzka-Rystwej, P. (2021). Immunological Prognostic Factors in Multiple Myeloma. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22073587"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1200\/EDBK_320105","article-title":"How to treat high-risk myeloma at diagnosis and relapse","volume":"41","author":"Caro","year":"2021","journal-title":"Am. Soc. Clin. Oncol. Ed. Book."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/s41375-019-0595-5","article-title":"The relative importance of factors predicting outcome for myeloma patients at different ages: Results from 3894 patients in the Myeloma XI trial","volume":"34","author":"Pawlyn","year":"2020","journal-title":"Leukemia"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1182\/blood-2018-09-825331","article-title":"Toward personalized treatment in multiple myeloma based on molecular characteristics","volume":"133","author":"Pawlyn","year":"2019","journal-title":"Blood"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Zhang, W., Gao, Z., Guan, M., Liu, N., Meng, F., and Wang, G. (2021). ASF1B Promotes Oncogenesis in Lung Adenocarcinoma and Other Cancer Types. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.731547"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.18632\/oncotarget.6223","article-title":"MEF2 transcription factors: Developmental regulators and emerging cancer genes","volume":"7","author":"Pon","year":"2016","journal-title":"Oncotarget"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.molcel.2019.09.030","article-title":"Mechanisms Controlling PD-L1 Expression in Cancer","volume":"76","author":"Cha","year":"2019","journal-title":"Mol. Cell"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"102737","DOI":"10.1155\/2008\/102737","article-title":"The Role of PPARs in Cancer","volume":"2008","author":"Tachibana","year":"2008","journal-title":"PPAR Res."},{"key":"ref_23","first-page":"93","article-title":"High expression of fibronectin 1 indicates poor prognosis in gastric cancer","volume":"19","author":"Sun","year":"2020","journal-title":"Oncol. Lett."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Dratwa, M., Wysocza\u0144ska, B., \u0141acina, P., Kubik, T., and Bogunia-Kubik, K. (2020). TERT-Regulation and Roles in Cancer Formation. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.589929"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"9924473","DOI":"10.1155\/2021\/9924473","article-title":"Role of Metastasis Suppressor KAI1\/CD82 in Different Cancers","volume":"2021","author":"Yan","year":"2021","journal-title":"J. Oncol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.matbio.2022.06.009","article-title":"Aberrant TIMP-1 overexpression in tumor-associated fibroblasts drives tumor progression through CD63 in lung adenocarcinoma","volume":"111","author":"Duch","year":"2022","journal-title":"Matrix Biol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"pbae016","DOI":"10.1093\/pcmedi\/pbae016","article-title":"Computational insights into CRISP3 downregulation in cervical cancer and its cervical lineages pattern","volume":"7","author":"Cintra","year":"2024","journal-title":"Precis. Clin. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0300-9084(01)01356-6","article-title":"TP53: A key gene in human cancer","volume":"84","author":"Guimaraes","year":"2002","journal-title":"Biochimie"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1002\/1878-0261.12457","article-title":"Mutual regulation of MDM4 and TOP2A in cancer cell proliferation","volume":"13","author":"Liu","year":"2019","journal-title":"Mol. Oncol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.3389\/fimmu.2019.01121","article-title":"Cell of Origin and Genetic Alterations in the Pathogenesis of Multiple Myeloma","volume":"10","author":"Barwick","year":"2019","journal-title":"Front Immunol."},{"key":"ref_31","first-page":"727","article-title":"PD-1\/PD-L1 pathway: Current researches in cancer","volume":"10","author":"Han","year":"2020","journal-title":"Am. J. Cancer Res."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Tamura, H., Ishibashi, M., Sunakawa-Kii, M., and Inokuchi, K. (2020). PD-L1-PD-1 Pathway in the Pathophysiology of Multiple Myeloma. Cancers, 12.","DOI":"10.3390\/cancers12040924"},{"key":"ref_33","first-page":"5558","article-title":"Activation of peroxisome proliferator-activated receptor gamma by troglitazone inhibits cell growth through the increase of p27KiP1 in human. Pancreatic carcinoma cells","volume":"60","author":"Motomura","year":"2000","journal-title":"Cancer Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"6414","DOI":"10.1158\/1078-0432.CCR-08-0457","article-title":"Peroxisome proliferator-activated receptor gamma overexpression suppresses growth and induces apoptosis in human multiple myeloma cells","volume":"14","author":"Bernstein","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Zhang, X.X., Luo, J.H., and Wu, L.Q. (2022). FN1 overexpression is correlated with unfavorable prognosis and immune infiltrates in breast cancer. Front. Genet., 13.","DOI":"10.3389\/fgene.2022.913659"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Geng, Q.S., Huang, T., Li, L.F., Shen, Z.B., Xue, W.H., and Zhao, J. (2022). Over-Expression and Prognostic Significance of FN1, Correlating with Immune Infiltrates in Thyroid Cancer. Front. Med., 8.","DOI":"10.3389\/fmed.2021.812278"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"e33388","DOI":"10.1097\/MD.0000000000033388","article-title":"High FN1 expression is associated with poor survival in esophageal squamous cell carcinoma","volume":"102","author":"Ma","year":"2023","journal-title":"Medicine"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1369\/jhc.2008.952200","article-title":"Altered expression of fibronectin and collagens I and IV in multiple myeloma and monoclonal gammopathy of undetermined significance","volume":"57","author":"Tancred","year":"2009","journal-title":"J. Histochem. Cytochem."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"6172","DOI":"10.1038\/s41388-019-0872-9","article-title":"Mechanisms underlying the activation of TERT transcription and telomerase activity in human cancer: Old actors and new players","volume":"38","author":"Yuan","year":"2019","journal-title":"Oncogene"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"e23133","DOI":"10.1002\/jcla.23133","article-title":"Prognostic relevance of telomere length and telomerase reverse transcriptase variant (rs2242652) on the multiple myeloma patients","volume":"34","author":"Aref","year":"2020","journal-title":"J. Clin. Lab. Anal."},{"key":"ref_41","first-page":"519","article-title":"KAI-1\/CD82, the molecule and clinical implication in cancer and cancer metastasis","volume":"24","author":"Malik","year":"2009","journal-title":"Histol. Histopathol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1096\/fj.06-6610com","article-title":"Overexpression of tetraspanins affects multiple myeloma cell survival and invasive potential","volume":"21","author":"Tohami","year":"2007","journal-title":"FASEB J."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Li, Y.Y., Zhang, L.Y., Xiang, Y.H., Li, D., and Zhang, J. (2023). Matrix metalloproteinases and tissue inhibitors in multiple myeloma: Promote or inhibit?. Front. Oncol., 13.","DOI":"10.3389\/fonc.2023.1127407"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.bbamcr.2010.01.003","article-title":"The tissue inhibitors of metalloproteinases (TIMPs): An ancient family with structural and functional diversity","volume":"1803","author":"Brew","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s13046-016-0427-7","article-title":"TIMP1 is a prognostic marker for the progression and metastasis of colon cancer through FAK-PI3K\/AKT and MAPK pathway","volume":"35","author":"Song","year":"2016","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Ishihara, R., Oda, T., Murakami, Y., Matsumura, I., Watanabe, S., Asao, Y., Masuda, Y., Gotoh, N., Kasamatsu, T., and Takei, H. (2023). Myeloma Microenvironmental TIMP1 Induces the Invasive Phenotype in Fibroblasts to Modulate Disease Progression. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24032216"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.leukres.2009.08.035","article-title":"High levels of serum TIMP-1 correlate with advanced disease and predict for poor survival in patients with multiple myeloma treated with novel agents","volume":"34","author":"Terpos","year":"2010","journal-title":"Leuk. Res."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3892\/ol.2011.418","article-title":"Copy number changes of CRISP3 in oral squamous cell carcinoma","volume":"3","author":"Ko","year":"2012","journal-title":"Oncol. Lett."},{"key":"ref_49","first-page":"5167","article-title":"In silico analysis identifies CRISP3 as a potential peripheral blood biomarker for multiple myeloma: From data modeling to validation with RT-PCR","volume":"15","author":"Leng","year":"2018","journal-title":"Oncol. Lett."},{"key":"ref_50","first-page":"1118","article-title":"Pivotal role of microRNA-138 in human cancers","volume":"9","author":"Yeh","year":"2019","journal-title":"Am. J. Cancer Res."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"111869","DOI":"10.1016\/j.mrfmmm.2024.111869","article-title":"MicroRNA-138 promotes the progression of multiple myeloma through targeting paired PAX5","volume":"829","author":"Yan","year":"2024","journal-title":"Mutat. Res."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1631\/jzus.B1300192","article-title":"Deregulation of microRNA expression in thyroid tumors","volume":"15","author":"Yuan","year":"2014","journal-title":"J. Zhejiang Univ. Sci. B"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"3633","DOI":"10.3892\/ol.2016.5038","article-title":"MicroRNA-138 inhibits proliferation, migration and invasion through targeting hTERT in cervical cancer","volume":"12","author":"Zhou","year":"2016","journal-title":"Oncol. Lett."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1080\/10715762.2017.1423070","article-title":"TIMP-1 suppressed by miR-138 participates in endoplasmic reticulum stress-induced osteoblast apoptosis in osteoporosis","volume":"52","author":"Yan","year":"2018","journal-title":"Free Radic. Res."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Rostami, F., Tavakol Hamedani, Z., Sadoughi, A., Mehrabadi, M., and Kouhkan, F. (2024). PDL1 targeting by miR-138-5p amplifies anti-tumor immunity and Jurkat cells survival in non-small cell lung cancer. Sci. Rep., 14.","DOI":"10.1038\/s41598-024-62064-5"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3233\/CBM-182182","article-title":"MiR-19b and miR-20a suppress apoptosis, promote proliferation and induce tumorigenicity of multiple myeloma cells by targeting PTEN","volume":"24","author":"Yuan","year":"2019","journal-title":"Cancer Biomark."},{"key":"ref_57","first-page":"5441","article-title":"miRNA-10a promotes cancer cell proliferation in oral squamous cell carcinoma by upregulating GLUT1 and promoting glucose metabolism","volume":"17","author":"Chen","year":"2019","journal-title":"Oncol. Lett."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2171283","DOI":"10.1080\/01443615.2023.2171283","article-title":"Upregulation of miRNA-10a-5p promotes tumor progression in cervical cancer by suppressing UBE2I signaling","volume":"43","author":"Gu","year":"2023","journal-title":"J. Obstet. Gynaecol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"30239","DOI":"10.18632\/oncotarget.4972","article-title":"MiRNA-10a is upregulated in NSCLC and may promote cancer by targeting PTEN","volume":"6","author":"Yu","year":"2015","journal-title":"Oncotarget"},{"key":"ref_60","first-page":"5994","article-title":"MicroRNA-10a suppresses breast cancer progression via PI3K\/Akt\/mTOR pathway","volume":"14","author":"Ke","year":"2017","journal-title":"Oncol. Lett."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1007\/s13238-016-0316-z","article-title":"miR-10a inhibits cell proliferation and promotes cell apoptosis by targeting BCL6 in diffuse large B-cell lymphoma","volume":"7","author":"Fan","year":"2016","journal-title":"Protein Cell"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.2147\/OTT.S103481","article-title":"Prognostic significance of miR-126 in various cancers: A meta-analysis","volume":"9","author":"Dong","year":"2016","journal-title":"Onco Targets Ther."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1100\/tsw.2010.198","article-title":"miR-126 and miR-126*: New players in cancer","volume":"10","author":"Meister","year":"2010","journal-title":"Sci. World J."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"e33085","DOI":"10.1097\/MD.0000000000033085","article-title":"The clinical validity of miR-126 as a prognostic marker in epithelial ovarian cancer","volume":"102","author":"Liu","year":"2023","journal-title":"Medicine"},{"key":"ref_65","first-page":"6873","article-title":"MiR-126 induces myeloma cell line Karpas707 apoptosis by downregulating anti-apoptotic protein MCL","volume":"22","author":"Liu","year":"2018","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Poli, V., Secl\u00ec, L., and Avalle, L. (2020). The Microrna-143\/145 Cluster in Tumors: A Matter of Where and When. Cancers, 12.","DOI":"10.3390\/cancers12030708"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1007\/s00432-019-02896-1","article-title":"Clinical significance of circulatory microRNA-203 in serum as novel potential diagnostic marker for multiple myeloma","volume":"145","author":"Gupta","year":"2019","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3892\/etm.2022.11155","article-title":"miR-146b-5p promotes colorectal cancer progression by targeting TRAF6","volume":"23","author":"Shi","year":"2022","journal-title":"Exp. Ther. Med."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.7150\/jca.16961","article-title":"MiR-146b-5p functions as a suppressor miRNA and prognosis predictor in non-small cell lung cancer","volume":"8","author":"Li","year":"2017","journal-title":"J. Cancer"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1016\/j.humpath.2014.04.002","article-title":"Low expression of microRNA-146b-5p and microRNA-320d predicts poor outcome of large B-cell lymphoma treated with cyclophosphamide, doxorubicin, vincristine, and prednisone","volume":"45","author":"Wu","year":"2014","journal-title":"Hum. Pathol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"e23168","DOI":"10.1002\/jcla.23168","article-title":"MicroRNA-146b overexpression associates with deteriorated clinical characteristics, increased International Staging System stage, cacoethic chromosome abnormality, and unfavorable prognosis in multiple myeloma patients","volume":"34","author":"Bao","year":"2020","journal-title":"J. Clin. Lab. Anal."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1080\/15384101.2020.1807081","article-title":"miR-146b-5p regulates bone marrow mesenchymal stem cell differentiation by SIAH2\/PPAR\u03b3 in aplastic anemia children and benzene-induced aplastic anemia mouse model","volume":"19","author":"Li","year":"2020","journal-title":"Cell Cycle"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"4465","DOI":"10.2147\/OTT.S143612","article-title":"Oncogenic role of microRNA-20a in human multiple myeloma","volume":"10","author":"Wang","year":"2017","journal-title":"Onco Targets Ther."},{"key":"ref_74","first-page":"10001","article-title":"Effects of microRNA-20a on the proliferation, migration and apoptosis of multiple myeloma via the PTEN\/PI3K\/AKT signaling pathway","volume":"15","author":"Jiang","year":"2018","journal-title":"Oncol. Lett."},{"key":"ref_75","first-page":"87","article-title":"Overexpression of miR-20a promotes the progression of osteosarcoma by directly targeting QKI2","volume":"18","author":"Yang","year":"2019","journal-title":"Oncol. Lett."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3892\/ol.2022.13269","article-title":"MicroRNA-20a promotes non-small cell lung cancer proliferation by upregulating PD-L1 by targeting PTEN","volume":"23","author":"Gong","year":"2022","journal-title":"Oncol. Lett."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1158\/1078-0432.CCR-12-3325","article-title":"Targeting miR-21 inhibits in vitro and in vivo multiple myeloma cell growth","volume":"19","author":"Leone","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/cbf.3051","article-title":"Silencing of TERT decreases levels of miR-1, miR-21, miR-29a and miR-208a in cardiomyocytes","volume":"32","author":"Drevytska","year":"2014","journal-title":"Cell Biochem. Funct."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"5638","DOI":"10.1002\/cam4.2489","article-title":"MicroRNA-124: An emerging therapeutic target in cancer","volume":"8","author":"Jia","year":"2019","journal-title":"Cancer Med."},{"key":"ref_80","first-page":"23","article-title":"Indirect Tumor Inhibitory Effects of MicroRNA-124 through Targeting EZH2 in The Multiple Myeloma Cell Line","volume":"22","author":"Mohammdi","year":"2020","journal-title":"Cell J."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"7071","DOI":"10.1002\/jcp.30378","article-title":"MicroRNA-124-3p suppresses PD-L1 expression and inhibits tumorigenesis of colorectal cancer cells via modulating STAT3 signaling","volume":"236","author":"Rasmi","year":"2021","journal-title":"J. Cell Physiol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.bbrc.2017.03.106","article-title":"Activation of PPAR\u03b3 inhibits pro-inflammatory cytokines production by upregulation of miR-124 in vitro and in vivo","volume":"486","author":"Wang","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1080\/10245332.2018.1502961","article-title":"miR-29b inhibits the progression of multiple myeloma through downregulating FOXP1","volume":"24","author":"Wang","year":"2019","journal-title":"Hematology"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"3650","DOI":"10.4161\/cc.26585","article-title":"miR-29b induces SOCS-1 expression by promoter demethylation and negatively regulates migration of multiple myeloma and endothelial cells","volume":"12","author":"Amodio","year":"2013","journal-title":"Cell Cycle"},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Veryaskina, Y.A., Titov, S.E., Ivanov, M.K., Ruzankin, P.S., Tarasenko, A.S., Shevchenko, S.P., Kovynev, I.B., Stupak, E.V., Pospelova, T.I., and Zhimulev, I.F. (2022). Selection of reference genes for quantitative analysis of microRNA expression in three different types of cancer. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0254304"},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Veryaskina, Y.A., Titov, S.E., Kovynev, I.B., Pospelova, T.I., and Zhimulev, I.F. (2020). The miRNA Profile in Non-Hodgkin\u2019s Lymphoma Patients with Secondary Myelodysplasia. Cells, 9.","DOI":"10.3390\/cells9102318"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Titov, S.E., Ivanov, M.K., Demenkov, P.S., Katanyan, G.A., Kozorezova, E.S., Malek, A.V., Veryaskina, Y.A., and Zhimulev, I.F. (2019). Combined quantitation of HMGA2 mRNA, microRNAs, and mitochondrial-DNA content enables the identification and typing of thyroid tumors in fine-needle aspiration smears. BMC Cancer, 19.","DOI":"10.1186\/s12885-019-6154-7"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/24\/13404\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:55:05Z","timestamp":1760115305000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/24\/13404"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,13]]},"references-count":88,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["ijms252413404"],"URL":"https:\/\/doi.org\/10.3390\/ijms252413404","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,13]]}}}